Abstract:Background: Lung cancer bone metastasis causes poor prognosis. Basigin-2, a novel cancer-associated biomarker, is upregulated in lung cancer and has been linked with tumor progression. But little is known about the role of basigin-2 in lung cancer bone metastasis and osteolytic lesion. Methods: Basigin-2 expression was evaluated in biopsy tissue specimens of 20 lung cancer patients with bone metastases via immunohistochemistry. Invasion assay and MTT proliferation assay were performed to test the invasion and proliferation of lung cancer cell after modulated basigin-2 expression. The osteoclastic activity of basigin-2 was detected in tibia cancer model by injected of lung cancer cells. The regulation role of receptor activator of NF-κB ligand (RANKL) on basigin-2 and its downstream molecules were measured by real-time quantitative RT-PCR, gelatin zymography and western blot analysis. Results: We found that basigin-2 was highly expressed in lung cancer bone metastases. Then, we demonstrated that basigin-2 could promote lung cancer cells invasion, metastasis and proliferation through upregulating metalloproteinases-2 (MMP-2), MMP-9 and vascular endothelial growth factor (VEGF) expression. The lung cancer cells overexpressing basigin-2 strongly induced the osteolytic lesions in immunodeficient mice, which were reduced by treatment with basigin-2 blocking antibody. Furthermore, we explored the enhanced basigin-2 molecular mechanism in lung cancer bone metastasis. Our results indicated the RANKL, pivotal for the control of bone resorption, could increase basigin-2 and its downstream molecules MMP-2, MMP-9 and VEGF expression in vitro. Conclusions: Basigin-2 upregulated by RANKL induces MMPs and VEGF, which may increase lung cancer cell metastasis ability and support osteoclastic activity. Thus, our data suggest important roles for basigin-2 in lung cancer-induced osteolytic lesion and implicate this protein potential application as a target for lung cancer bone metastasis therapy.

SPON2 promotes the bone metastasis of lung adenocarcinoma via activation of the NF-κB signaling pathway

Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC

Spon1+ inflammatory monocytes promote collagen remodeling and lung cancer metastasis through lipoprotein receptor 8 signaling

Increased SPON1 Promotes Pancreatic Ductal Adenocarcinoma Progression by Enhancing IL-6 Trans-Signalling

Spondin 2 Promotes the Proliferation, Migration and Invasion of Gastric Cancer Cells

Data from SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin–Rho GTPase–Hippo Pathways

The biological functions and related signaling pathways of SPON2

Tumor-derived Exosomal HOTAIRM1 Regulates SPON2 in CAFs to Promote Progression of Lung Adenocarcinoma

SPNS2 Downregulation Induces EMT and Promotes Colorectal Cancer Metastasis Via Activating AKT Signaling Pathway

Upregulation of Spondin-2 Protein Expression Correlates with Poor Prognosis in Hepatocellular Carcinoma

Bone sialoprotein promotes lung cancer osteolytic bone metastasis via MMP14-dependent mechanisms

P2-109: Predictive Significance of Bone Sialoprotein and Osteopontin for Bone Metastases in Respectable Non-Small-Cell Lung Cancer:A Retrospective Study

SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α

Basigin-2 upregulated by receptor activator of NF-κB ligand enhances lung cancer-induced osteolytic lesions

SPHK1 Promotes HNSCC Immune Evasion by Regulating the MMP1-PD-L1 Axis

OPN-a Splicing Variant Expression in Non-small Cell Lung Cancer and Its Effects on the Bone Metastatic Abilities of Lung Cancer Cells in Vitro.

Osteopontin As a Multifaceted Driver of Bone Metastasis and Drug Resistance

Transcriptional Activation of Matricellular Protein Spondin2 (SPON2) by BRG1 in Vascular Endothelial Cells Promotes Macrophage Chemotaxis

BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activation

Spondin-2, a secreted extracellular matrix protein, is a novel diagnostic biomarker for prostate cancer

XCR1 Promotes Cell Growth and Migration and is Correlated with Bone Metastasis in Non-Small Cell Lung Cancer.